Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

554 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial.
Azizi M, Sapoval M, Gosse P, Monge M, Bobrie G, Delsart P, Midulla M, Mounier-Véhier C, Courand PY, Lantelme P, Denolle T, Dourmap-Collas C, Trillaud H, Pereira H, Plouin PF, Chatellier G; Renal Denervation for Hypertension (DENERHTN) investigators. Azizi M, et al. Among authors: chatellier g. Lancet. 2015 May 16;385(9981):1957-65. doi: 10.1016/S0140-6736(14)61942-5. Epub 2015 Jan 26. Lancet. 2015. PMID: 25631070 Clinical Trial.
Renal denervation for resistant hypertension - Authors' reply.
Azizi M, Pereira H, Bobrie G, Gosse P, Chatellier G; Renal Denervation for Hypertension (DENERHTN) investigators. Azizi M, et al. Among authors: chatellier g. Lancet. 2015 Sep 26;386(10000):1240. doi: 10.1016/S0140-6736(15)00259-7. Lancet. 2015. PMID: 26460654 No abstract available.
Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial.
Azizi M, Pereira H, Hamdidouche I, Gosse P, Monge M, Bobrie G, Delsart P, Mounier-Véhier C, Courand PY, Lantelme P, Denolle T, Dourmap-Collas C, Girerd X, Michel Halimi J, Zannad F, Ormezzano O, Vaïsse B, Herpin D, Ribstein J, Chamontin B, Mourad JJ, Ferrari E, Plouin PF, Jullien V, Sapoval M, Chatellier G; DENERHTN Investigators. Azizi M, et al. Among authors: chatellier g. Circulation. 2016 Sep 20;134(12):847-57. doi: 10.1161/CIRCULATIONAHA.116.022922. Epub 2016 Aug 30. Circulation. 2016. PMID: 27576780 Clinical Trial.
Medical and Economic Evaluation of FOREseal Bioabsorbable Reinforcement Sleeves Compared With Current Standard of Care for Reducing Air Leakage Duration After Lung Resection for Malignancy: A Randomized Trial.
Alifano M, Jayle C, Bertin F, Magdeleinat P, Castier Y, Tiffet O, Bernard A, Tronc F, Brichon PY, Dumont P, Grosdidier G, Dujon A, Grine A, Pereira H, Le Jeannic A, Vinet MA, MaOulida H, Durand-Zaleski I, Riquet M, Chatellier G, Regnard JF; FOREseal Investigators. Alifano M, et al. Among authors: chatellier g. Ann Surg. 2017 Jan;265(1):45-53. doi: 10.1097/SLA.0000000000001687. Ann Surg. 2017. PMID: 28009728 Clinical Trial.
Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension).
Gosse P, Cremer A, Pereira H, Bobrie G, Chatellier G, Chamontin B, Courand PY, Delsart P, Denolle T, Dourmap C, Ferrari E, Girerd X, Michel Halimi J, Herpin D, Lantelme P, Monge M, Mounier-Vehier C, Mourad JJ, Ormezzano O, Ribstein J, Rossignol P, Sapoval M, Vaïsse B, Zannad F, Azizi M. Gosse P, et al. Among authors: chatellier g. Hypertension. 2017 Mar;69(3):494-500. doi: 10.1161/HYPERTENSIONAHA.116.08448. Epub 2017 Jan 23. Hypertension. 2017. PMID: 28115517 Clinical Trial.
554 results